High Dose Chemotherapy Followed By PBSC Rescue for HD

Stanford University200 enrolled

Overview

To evaluate the role of high dose chemotherapy with autologous hematopoietic cell transplantation in the treatment of Hodgkin's Disease.

Use of High Dose Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Relapsed or Resistant Hodgkin's Disease

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

200

Sex: ALLMin age: 4 WeeksMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria:- adequate organ function * recurrent HD Exclusion Criteria:- CNS disease * no prior malignancy

Stanford University School of Medicine

Stanford, California, United States

Overall survival

FFS

Response rates

Toxicity of high dose chemotherapy

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.